In prostate and lung cancers (LCs), resveratrol incites a downregulation of stromal interaction molecule 1 (STIM1) and an inactivation of the mTOR pathway whereas in colorectal cancer, it boosts autophagy by increasing reactive oxygen species (ROS) production and inducing caspases-8 and−3 (Miki et al., 2012). The gene discussed is STIM1; the disease is lung carcinoma.